date,title,source
Oct-17-18,Cue Biopharma Announces Strategic Research Collaboration with Albert Einstein College of Medicine to Further the Potential of Immuno-STAT Platform in Chronic Infectious Diseases,GlobeNewswire
Oct-24-18,"Dr. Anish Suri, Cue Biopharmas CSO, to Present at Upcoming Precision: Lung Cancer Summit",GlobeNewswire
Oct-30-18,Cue Biopharma Announces Presentation at the Society for Immunotherapy of Cancers (SITC) 33rd Annual Meeting,GlobeNewswire
Nov-08-18,Cue Biopharma Announces Strategic Collaboration with LG Chem Life Sciences for Immuno-STAT Biologics in Oncology,GlobeNewswire
Nov-14-18,Cue Biopharma to Host Business Update Call and Webcast,GlobeNewswire
Dec-20-18,Cue Biopharma and LG Chem Life Sciences Announce WT1 as the Next Immuno-STAT Target in Oncology,GlobeNewswire
Jan-07-19,"3 Stock Charts for Monday: Gap, CenterPoint Energy and Boston Scientific",InvestorPlace
Jan-16-19,Cue Biopharma Announces Presentation Highlighting Immuno-STAT Platform and CUE-101 at the 2019 Keystone Symposia Conference,GlobeNewswire
Jan-31-19,"Cue Biopharma, Inc. (NASDAQ:CUE) Insiders Increased Their Holdings",Simply Wall St.
Mar-07-19,Cue Biopharma to Host Business Update Call and Webcast,GlobeNewswire
Mar-14-19,Cue Biopharma to Present Corporate Overview and Update at the Oppenheimer 29th Annual Healthcare Conference,GlobeNewswire
Apr-08-19,Cue Biopharma to Present Immuno-STAT Platform Technology at PEGs Boston 2019,GlobeNewswire
Apr-29-19,"If You Had Bought Cue Biopharma (NASDAQ:CUE) Stock A Year Ago, You'd Be Sitting On A 25% Loss, Today",Simply Wall St.
May-09-19,"Dr. Anish Suri, Cue Biopharmas CSO, to Participate in Panel Discussion at Upcoming NYAS Frontiers in Cancer Immunotherapy Conference",GlobeNewswire
May-16-19,Cue Biopharma to Host Business Update Call and Webcast,GlobeNewswire
May-16-19,"Cue Biopharma Announces FDA Acceptance of IND for Lead Immuno-oncology Candidate, CUE-101, in Treatment of HPV-driven Cancers",GlobeNewswire
